MedPath

Comparison of intravenous Magnesium sulfate and intravenous Tramadol for prevention of post spinal shivering in patients undergoing lower limb Orthopedic surgery.

Not Applicable
Conditions
Health Condition 1: M849- Disorder of continuity of bone, unspecifiedHealth Condition 2: M849- Disorder of continuity of bone, unspecifiedHealth Condition 3: M849- Disorder of continuity of bone, unspecified
Registration Number
CTRI/2021/06/034048
Lead Sponsor
Satyajeet Singh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.American Society of Anesthesiologistsâ?? Physical Status I & II.

2.Patients posted for lower limb orthopaedic surgery under spinal anesthesia in Peoples Hospital.

Exclusion Criteria

1.American Society of Anesthesiologistsâ?? physical Status III & IV.

2.Patients with Severe cardiopulmonary, renal or liver disease

3.Morbidly obese patients

4.Basal body temperature of patiens >38°C or <36°C

5.Those who received blood transfusion or >2500 ml fluid

6.Patients Allergic to study drug

7.Patients refusing to give consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tramadol and Magnesium sulfate both are equally effective in postspinal shivering.Timepoint: 1 hour
Secondary Outcome Measures
NameTimeMethod
Tramadol and Magnesium sulfate both are equally effective in postspinal shivering.Timepoint: 1 hour
© Copyright 2025. All Rights Reserved by MedPath